Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 15.4 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue growth | | | | -100.0% | |
| Cost of goods sold | 0.1 | 0.0 | 0.0 | 0.0 | -1.8 |
| Gross profit | 15.4 | 0.0 | 0.0 | 0.0 | 1.7 |
| Gross margin | 99.5% | | | | -6063.1% |
| Research and development | 9.3 | 9.8 | 5.1 | 1.9 | 0.0 |
| General and administrative | 6.0 | 4.7 | 4.4 | 2.0 | 0.9 |
| EBIT | -15.2 | -14.5 | -9.5 | -3.8 | -0.9 |
| EBIT margin | -98.2% | | | | 3081.6% |
| Pre-tax income | -15.3 | -14.5 | -9.5 | -3.9 | -7.4 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -15.3 | -14.5 | -9.5 | -3.9 | -7.4 |
| Net margin | -98.9% | | | | 25832.3% |
| |
| Diluted EPS | ($11.22) | ($16.50) | ($0.57) | ($0.28) | ($0.70) |
| Shares outstanding (diluted) | 1.4 | 0.9 | 16.6 | 13.6 | 10.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|